Correlation Between Catalyst Biosciences and Bellerophon Therapeutics

Can any of the company-specific risk be diversified away by investing in both Catalyst Biosciences and Bellerophon Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Biosciences and Bellerophon Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Catalyst Biosciences and Bellerophon Therapeutics, you can compare the effects of market volatilities on Catalyst Biosciences and Bellerophon Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Biosciences with a short position of Bellerophon Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Biosciences and Bellerophon Therapeutics.

Diversification Opportunities for Catalyst Biosciences and Bellerophon Therapeutics

0.0

Correlation Coefficient

Catalyst Biosciences  Bellerophon Therapeutics

Pay attention - limited upside

The 3 months correlation between Catalyst and Bellerophon is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Biosciences and Bellerophon Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bellerophon Therapeutics and Catalyst Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Biosciences are associated (or correlated) with Bellerophon Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bellerophon Therapeutics has no effect on the direction of Catalyst Biosciences i.e., Catalyst Biosciences and Bellerophon Therapeutics go up and down completely randomly.

Pair Corralation between Catalyst Biosciences and Bellerophon Therapeutics

If you would invest (100.00) in Bellerophon Therapeutics on December 2, 2024 and sell it today you would earn a total of  100.00  from holding Bellerophon Therapeutics or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Catalyst Biosciences  vs.  Bellerophon Therapeutics

Catalyst Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Catalyst Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Catalyst Biosciences is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Bellerophon Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bellerophon Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Bellerophon Therapeutics is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Catalyst Biosciences and Bellerophon Therapeutics

The main advantage of trading using opposite Catalyst Biosciences and Bellerophon Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Biosciences position performs unexpectedly, Bellerophon Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bellerophon Therapeutics will offset losses from the drop in Bellerophon Therapeutics' long position.

The idea behind Catalyst Biosciences and Bellerophon Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.